[go: up one dir, main page]

Podlisny et al., 1995 - Google Patents

Aggregation of secreted amyloid β-protein into sodium dodecyl sulfate-stable oligomers in cell culture

Podlisny et al., 1995

View HTML
Document ID
17990134487164526704
Author
Podlisny M
Ostaszewski B
Squazzo S
Koo E
Rydell R
Teplow D
Selkoe D
Publication year
Publication venue
Journal of Biological Chemistry

External Links

Snippet

Filamentous aggregates of the 40-42-residue amyloid β-protein (Aβ) accumulate progressively in the limbic and cerebral cortex in Alzheimer's disease, where they are intimately associated with neuronal and glial cytopathology. Attempts to model this …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Similar Documents

Publication Publication Date Title
Podlisny et al. Aggregation of secreted amyloid β-protein into sodium dodecyl sulfate-stable oligomers in cell culture
EP0667959B1 (en) Methods for identifying inhibitors of the production of beta-amyloid peptide
US6284221B1 (en) Method for identifying β-amyloid peptide production inhibitors
US5766846A (en) Methods of screening for compounds which inhibit soluble β-amyloid peptide production
US5652092A (en) Amyloid precursor proteins and method of using same to assess agents which down-regulate formation of β-amyloid peptide
Selkoe Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease
Podlisny et al. Presenilin proteins undergo heterogeneous endoproteolysis between Thr291and Ala299and occur as stable N-and C-terminal fragments in normal and Alzheimer brain tissue
Chauhan et al. Binding of gelsolin, a secretory protein, to amyloid β-protein
US6018024A (en) Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein
Selkoe Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease
US5538845A (en) Beta-amyloid peptide production inhibitors and methods for their identification
Ho et al. The alternatively spliced Kunitz protease inhibitor domain alters amyloid β protein precursor processing and amyloid β protein production in cultured cells
Higgins et al. P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain
US7479372B2 (en) Beta-secretase substrates and uses thereof
Sian et al. Oligomerization of β-amyloid of the Alzheimer’s and the Dutch-cerebral-haemorrhage types
Selkoe Cell biology of the β-amyloid precursor protein and the genetics of Alzheimer's disease
Levey et al. Presenilin‐1 protein expression in familial and sporadic Alzheimer's disease
AU687747C (en) Methods and compositions for the detection of soluble beta-amyloid peptide
AU722044B2 (en) Methods and compositions for the detection of soluble beta-amyloid peptide
AU2008200489B2 (en) Methods and compositions for the detection of soluble beta-amyloid peptide
AU2004203875A1 (en) Methods and compositions for the detection of soluble beta-amyloid peptide
Ho The alternatively spliced Kunitz protease inhibitor domain alters amyloid beta protein processing and amyloid beta protein production in cultured cells